PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 29.80
+0.10 (0.34%)
Apr 2, 2026, 5:30 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 980.29 million as of April 2, 2026. Its market cap has increased by 60.07% in one year.
Market Cap
980.29M
Enterprise Value
1.04B
Revenue
362.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.80
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 980.29M, a decrease of -62.16%. That is a compound annual growth rate of -17.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 980.29M | 13.85% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 250.96B |
| Novartis AG | 228.63B |
| Galderma Group AG | 35.11B |
| Lonza Group AG | 35.00B |
| Cosmo Pharmaceuticals | 1.30B |
| Aevis Victoria | 1.13B |
| Medartis Holding AG | 957.31M |
| SKAN Group AG | 921.82M |